Back to Sleep
SupplementPreliminary evidenceSleep

Glycine (3 g pre-bed)

Inhibitory amino acid with small RCT signal for subjective sleep quality at 3 g pre-bed.

Why

Glycine is a small inhibitory amino acid. Both a neurotransmitter and a collagen substrate. Small Japanese RCTs (Yamadera 2007, Bannai 2012) report improvements in subjective sleep quality and reduced daytime sleepiness with 3 g pre-bed. Mechanism appears to involve mild peripheral vasodilation that drops core body temperature (sleep-onset signal). Also used as collagen-synthesis substrate alongside vitamin C and other amino acids.

How it works

Activates NMDA-receptor glycine-binding site centrally and inhibitory glycine receptors in spinal cord. Peripherally, mild vasodilation drops core body temperature, the documented mechanism for the sleep-onset effect. Glycine is one of the three glycogenic amino acids in collagen (along with proline and hydroxyproline).

Expected onset · Sleep effects often within days (acute pharmacodynamic effect)

How to take

Dosage

Sleep: 3 g 30–60 min before bed. Collagen synthesis support: 5–10 g/day divided.

Timing

Sleep dose at bedtime; collagen dose across the day

On the label

'Glycine' powder is most cost-effective for the 3 g dose. Stated grams per scoop.

Ideal for

Adults with mild sleep-onset difficulty exploring nutrient-based approaches; people supporting collagen synthesis.

Safety

Generally very well tolerated. Mild GI upset at higher doses. Theoretical interaction with clozapine (glycine modulates NMDA receptor). Coordinate if relevant. Sweet taste; usually mixes well in water. Pregnancy: dietary intake fine; supplement-specific data limited.

Evidence

At a glance

Yamadera 2007 Sleep Biol Rhythms RCT: glycine 3 g pre-bed improved subjective sleep quality and PSG sleep-onset markers vs placebo. Bannai 2012 Front Neurol crossover RCT documented reduced daytime sleepiness after partial sleep restriction. Preliminary, RCTs exist in non-tier-1 journals but are small or short-duration. No Cochrane review, EMA monograph or EFSA-authorised claim covers the indication.

Limitations

Preliminary, RCTs exist in non-tier-1 journals but are small or short-duration. No Cochrane review, EMA monograph or EFSA-authorised claim covers the indication.

Where to get it

Shop Glycine (3 g pre-bed) on Amazon

Sponsored · As an Amazon Associate, Healicus earns from qualifying purchases.